SYNCELL has been invited to pitch at the upcoming Berkeley Skydeck and Taiwan Tech Arena (TTA) Global Innovation Showcase on August 19, 2021. The event will feature 10 innovative startups from Taiwan. The venue will be powered by Filo’s virtual exhibition platform and Skydeck has received several hundred meeting reservations including its advisory network, Silicon Valley investors and seasoned entrepreneurs. This exciting event will help connecting Taiwan startups with Skydeck’s extensive network for advice and funding.
Dr. Jung-Chi Liao, SYNCELL founder, will present SYNCELL’s Microscoop™ spatial biology technology and its business strategy to redefine the already heated spatial omics field. Dr. Liao expressed his excitement to participate in this event and the opportunity to fast-track SYNCELL with a direct path to the heart of Silicon Valley.
About SYNCELL Inc.
SYNCELL is a development stage company with a vision to revolutionize in situ cell biology and biomedical research. The company will soon introduce its groundbreaking Microscoop™ platform, the first and only system that allows users to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. Microscoop™ is pairing unique imaging and illuminating capabilities with novel photolabeling chemicals to provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, infectious disease, gene therapy, and to identify novel therapeutic targets with spatial context to accelerate drug discovery and development programs.
CONTACT:
Shuyi Liao
SYNCELL, Inc.
Phone +886-2-77505632
Info@syncell.com
Follow SYNCELL on LinkedIn at SYNCELL INC. and tag your posts with #syncell or #microscoop
SYNCELL has been invited to pitch at the upcoming Berkeley Skydeck and Taiwan Tech Arena (TTA) Global Innovation Showcase on August 19, 2021. The event will feature 10 innovative startups from Taiwan. The venue will be powered by Filo’s virtual exhibition platform and Skydeck has received several hundred meeting reservations including its advisory network, Silicon Valley investors and seasoned entrepreneurs. This exciting event will help connecting Taiwan startups with Skydeck’s extensive network for advice and funding.
Dr. Jung-Chi Liao, SYNCELL founder, will present SYNCELL’s Microscoop™ spatial biology technology and its business strategy to redefine the already heated spatial omics field. Dr. Liao expressed his excitement to participate in this event and the opportunity to fast-track SYNCELL with a direct path to the heart of Silicon Valley.
About SYNCELL Inc.
SYNCELL is a development stage company with a vision to revolutionize in situ cell biology and biomedical research. The company will soon introduce its groundbreaking Microscoop™ platform, the first and only system that allows users to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. Microscoop™ is pairing unique imaging and illuminating capabilities with novel photolabeling chemicals to provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, infectious disease, gene therapy, and to identify novel therapeutic targets with spatial context to accelerate drug discovery and development programs.
CONTACT:
Shuyi Liao
SYNCELL, Inc.
Phone +886-2-77505632
Info@syncell.com
Follow SYNCELL on LinkedIn at SYNCELL INC. and tag your posts with #syncell or #microscoop